Anti-BACE2 antibody (350-396) {FITC} (STJ500212)

SKU:
STJ500212-100

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: ELISA/IP/WB
Reactivity: Human/Monkey
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-BACE2 (350-396) is suitable for use in ELISA, Immunoprecipitation and Western Blot research applications.
Clonality: Polyclonal
Conjugation: FITC
Isotype: IgG
Purification: Affinity Purified
Concentration: 0.55-0.59 µg/µl
Dilution Range: WB: 1:500
DB: 1:10, 000
ELISA: 1:10, 000
IP: 1:200
Storage Instruction: Store at-20°C for long term storage. Avoid freeze-thaw cycles.
Gene Symbol: BACE2
Gene ID: 25825
Uniprot ID: BACE2_HUMAN
Immunogen Region: 350-396
Specificity: This antibody will only detect BACE2B. This antibody will not cross react with BACE2A or BACE2B.
Immunogen: Synthetic peptide taken within amino acid region 350-396 on human BACE2B protein.
Tissue Specificity Brain. Present in neurons within the hippocampus, frontal cortex and temporal cortex (at protein level). Expressed at low levels in most peripheral tissues and at higher levels in colon, kidney, pancreas, placenta, prostate, stomach and trachea. Expressed at low levels in the brain. Found in spinal cord, medulla oblongata, substantia nigra and locus coruleus. Expressed in the ductal epithelium of both normal and malignant prostate.
Post Translational Modifications Undergoes autoproteolytic cleavage. Glycosylated.
Function Responsible for the proteolytic processing of the amyloid precursor protein (APP). Cleaves APP, between residues 690 and 691, leading to the generation and extracellular release of beta-cleaved soluble APP, and a corresponding cell-associated C-terminal fragment which is later released by gamma-secretase. It has also been shown that it can cleave APP between residues 671 and 672. Involved in the proteolytic shedding of PMEL at early stages of melanosome biogenesis. Cleaves PMEL within the M-beta fragment to release the amyloidogenic PMEL luminal fragment containing M-alpha and a small portion of M-beta N-terminus. This is a prerequisite step for subsequent processing and assembly of PMEL fibrils into amyloid sheets. Responsible also for the proteolytic processing of CLTRN in pancreatic beta cells.
Protein Name Beta-Secretase 2
Aspartic-Like Protease 56 Kda
Aspartyl Protease 1
Asp1
Asp 1
Beta-Site Amyloid Precursor Protein Cleaving Enzyme 2
Beta-Site App Cleaving Enzyme 2
Down Region Aspartic Protease
Drap
Memapsin-1
Membrane-Associated Aspartic Protease 1
Theta-Secretase
Cellular Localisation Cell Membrane
Single-Pass Type I Membrane Protein
Golgi Apparatus
Endoplasmic Reticulum
Endosome
Melanosome
Colocalizes With Pmel In Stage I And Ii Melanosomes
Alternative Antibody Names Anti-Beta-Secretase 2 antibody
Anti-Aspartic-Like Protease 56 Kda antibody
Anti-Aspartyl Protease 1 antibody
Anti-Asp1 antibody
Anti-Asp 1 antibody
Anti-Beta-Site Amyloid Precursor Protein Cleaving Enzyme 2 antibody
Anti-Beta-Site App Cleaving Enzyme 2 antibody
Anti-Down Region Aspartic Protease antibody
Anti-Drap antibody
Anti-Memapsin-1 antibody
Anti-Membrane-Associated Aspartic Protease 1 antibody
Anti-Theta-Secretase antibody
Anti-BACE2 antibody
Anti-AEPLC antibody
Anti-ALP56 antibody
Anti-ASP21 antibody
Anti-CDA13 antibody
Anti-UNQ418 antibody
Anti-PRO852 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance